ArticleCancer chemotherapy and pharmacology2019

Dose adjustment of irinotecan based on UGT1A1 polymorphisms in patients with colorectal cancer.

Hironori Fujii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.